144
Participants
Start Date
October 31, 2024
Primary Completion Date
August 31, 2026
Study Completion Date
November 30, 2026
Non-Interventional
Non-interventional study
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Geisinger Medical Center, Danville
Helen F Graham Cancer Center, Newark
Christiana Care - Union Hospital, Elkton
Wake Forest NCORP Research Base, Winston-Salem
FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst
Prisma Health Cancer Institute - Butternut, Greenville
Prisma Health Cancer Institute - Faris, Greenville
Cancer Hematology Centers - Flint, Flint
Genesee Hematology Oncology PC, Flint
Genesys Hurley Cancer Institute, Flint
Mission Cancer and Blood - Ankeny, Ankeny
Iowa Methodist Medical Center, Des Moines
Mission Cancer and Blood - Des Moines, Des Moines
Aurora Cancer Care-Grafton, Grafton
Aurora Cancer Care-Kenosha South, Kenosha
Aurora Saint Luke's Medical Center, Milwaukee
ThedaCare Regional Cancer Center, Appleton
Essentia Health Cancer Center, Duluth
Hennepin County Medical Center, Minneapolis
Essentia Health Saint Joseph's Medical Center, Brainerd
Essentia Health Cancer Center-South University Clinic, Fargo
Illinois CancerCare-Peoria, Peoria
Carle Cancer Institute Normal, Normal
Carle Cancer Center, Urbana
Carle at The Riverfront, Danville
Carle Physician Group-Mattoon/Charleston, Mattoon
Carle Physician Group-Effingham, Effingham
Central Care Cancer Center - Bolivar, Bolivar
CoxHealth South Hospital, Springfield
University Medical Center New Orleans, New Orleans
FHP Health Center-Guam, Tamuning
MaineHealth Cancer Care - Brunswick, Brunswick
Penobscot Bay Medical Center, Rockport
Puerto Rico Hematology Oncology Group, Bayamón
Centro Comprensivo de Cancer de UPR, San Juan
San Juan City Hospital, San Juan
National Cancer Institute (NCI)
NIH
Wake Forest University Health Sciences
OTHER